Wu, L., Mo, W., Feng, J., Li, J., Yu, Q., Li, S., . . . Guo, C. (2020). Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non‐alcoholic fatty liver disease by up‐regulating the FGF21/PGC‐1α pathway. Br J Pharmacol.

Wu, Liwei, et al. "Astaxanthin Attenuates Hepatic Damage and Mitochondrial Dysfunction in Non‐alcoholic Fatty Liver Disease By Up‐regulating the FGF21/PGC‐1α Pathway." Br J Pharmacol 2020.

Wu, Liwei, et al. "Astaxanthin Attenuates Hepatic Damage and Mitochondrial Dysfunction in Non‐alcoholic Fatty Liver Disease By Up‐regulating the FGF21/PGC‐1α Pathway." Br J Pharmacol 2020.